Enhanced Drug Photosafety by Interchromophoric Interaction Owing to Intramolecular Charge Separation

Ming-De Li1, Zhiping Yan2, Ruixue Zhu2

  • 1Department of Chemistry and Key Laboratory for Preparation and Application of Ordered Structural Materials of Guangdong Province, Shantou University, Guangdong, 515063, P. R. China.

Insights

Imatinib, a cancer drug, shows low phototoxicity due to intramolecular charge separation. Its pyridylpyrimidine fragment is phototoxic, highlighting the role of interchromophoric interactions in drug photosafety.

Area of Science:

  • Photochemistry
  • Medicinal Chemistry
  • Molecular Biophysics

Background:

  • Imatinib is a cancer therapeutic with low DNA phototoxicity.
  • The pyridylpyrimidine fragment of imatinib exhibits significant phototoxicity.
  • The mechanism behind imatinib's enhanced photosafety is not well understood.

Purpose of the Study:

  • To investigate the excited state properties and interchromophoric interactions of imatinib.
  • To elucidate the mechanism of imatinib's photosafety.
  • To understand the phototoxicity of the pyridylpyrimidine fragment.

Main Methods:

  • Ultrafast laser flash photolysis.
  • Agarose electrophoresis.
  • Time-resolved resonance Raman spectroscopy.
  • Quenching studies.

Main Results:

  • Direct observation of intramolecular charge separation in irradiated imatinib, facilitating excited state relaxation.
  • Identification of an anionic form of the pyridylpyrimidine fragment.
  • Pyridylpyrimidine efficiently forms long-lived triplet excited states, correlating with its phototoxicity.

Conclusions:

  • Intramolecular charge separation contributes to imatinib's photosafety.
  • Interchromophoric interactions are crucial for modulating drug phototoxicity.
  • This study offers insights for designing safer or more photostable drugs.

Related Concept Videos

Intermolecular vs Intramolecular Forces03:00

Intermolecular vs Intramolecular Forces

Intermolecular forces (IMF) are electrostatic attractions arising from charge-charge interactions between molecules. The strength of the intermolecular force is influenced by the distance of separation between molecules. The forces significantly affect the interactions in solids and liquids, where the molecules are close together. In gases, IMFs become important only under high-pressure conditions (due to the proximity of gas molecules). Intermolecular forces dictate the physical properties of...
98.0K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
278
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
213
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
226
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
20
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
471